Abpro Holdings, Inc. — Investor Relations & Filings
Abpro Holdings, Inc. is a clinical-stage biotechnology company that develops next-generation antibody therapeutics. The company focuses on creating novel antibody constructs for challenging and high-value targets in immuno-oncology and ophthalmology. Its pipeline includes therapies targeting various cancers such as HER2-positive (HER2+) breast and gastric cancers, as well as non-HER2+ gastric, colorectal, and liver cancers. In ophthalmology, Abpro is developing treatments for conditions like wet age-related macular degeneration. The company utilizes its proprietary DiversImmune™ platform to engineer and discover its therapeutic candidates, aiming to address severe and life-threatening diseases with significant unmet medical needs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| QUARTERLY REPORT | 2025-05-15 | English | |
| Regulatory Filings 2025 | 2025-05-06 | English | |
| POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 | 2025-05-01 | English | |
| PRIMARY DOCUMENT | 2025-05-01 | English | |
| FORM ARS | 2025-04-30 | English | |
| PROXY STATEMENT | 2025-04-29 | English |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 13546913 | QUARTERLY REPORT | 2025-05-15 | English | ||
| 13546914 | Regulatory Filings 2025 | 2025-05-06 | English | ||
| 13546918 | POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 | 2025-05-01 | English | ||
| 13546919 | PRIMARY DOCUMENT | 2025-05-01 | English | ||
| 13546920 | FORM ARS | 2025-04-30 | English | ||
| 13546921 | PROXY STATEMENT | 2025-04-29 | English | ||
| 13546922 | CURRENT REPORT | 2025-04-28 | English | ||
| 13546923 | PRIMARY DOCUMENT | 2025-04-25 | English | ||
| 13546924 | CURRENT REPORT | 2025-04-24 | English | ||
| 13546925 | POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 | 2025-04-23 | English | ||
| 13546927 | PROSPECTUS SUPPLEMENT | 2025-04-23 | English | ||
| 13546928 | CURRENT REPORT | 2025-04-16 | English | ||
| 13546932 | ANNUAL REPORT | 2025-04-15 | English | ||
| 13546934 | CURRENT REPORT | 2025-04-15 | English | ||
| 13546935 | CURRENT REPORT | 2025-04-08 | English | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
|
ACROBIOSYSTEMS CO.,LTD.
Provides recombinant proteins and reagents for life science…
|
301080 | CN | Professional, scientific and te… |
Abpro Holdings, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34955/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34955 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34955 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34955 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34955}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Abpro Holdings, Inc. (id: 34955)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.